L-carnitine and contribution to normal lipid metabolism : evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Show simple item record

dc.contributor.author EFSA Panel Dietetic Prod Nut
dc.date.accessioned 2019-02-08T09:17:01Z
dc.date.available 2019-02-08T09:17:01Z
dc.date.issued 2018-01
dc.identifier.citation EFSA Panel Dietetic Prod Nut 2018 , ' L-carnitine and contribution to normal lipid metabolism : evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 ' , EFSA Journal , vol. 16 , no. 1 , 5137 . https://doi.org/10.2903/j.efsa.2018.5137
dc.identifier.other PURE: 121750537
dc.identifier.other PURE UUID: 177490f3-a5bf-42ef-af5e-992ce0e060e0
dc.identifier.other WOS: 000423808600034
dc.identifier.other ORCID: /0000-0002-9930-4009/work/53825694
dc.identifier.other Scopus: 85062077789
dc.identifier.uri http://hdl.handle.net/10138/298818
dc.description.abstract Following an application from Lonza Ltd., submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No1924/2006 via the Competent Authority of Germany, the EFSA Panelon Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to L-carnitine and normal lipid metabolism. The food that is proposed as the subject of the health claim is L-carnitine. The Panelconsiders that L-carnitine is sufficiently characterised. The claimed effect proposed by the applicant is normal lipid metabolism'. The target population proposed by the applicant is the general population. The Panelconsiders that contribution to normal lipid metabolism is a beneficial physiological effect. The applicant proposes that the claim submitted with this application is based on the essentiality of a nutrient. The Panelconsiders that the evidence provided does not establish that dietary L-carnitine is required to maintain normal lipid metabolism in the target population, for which the claim is intended. The Panelconcludes that a cause and effect relationship has not been established between the consumption of L-carnitine and contribution to normal lipid metabolism in the target population. (c) 2018 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority. en
dc.format.extent 9
dc.language.iso eng
dc.relation.ispartof EFSA Journal
dc.rights cc_by_nd
dc.rights.uri info:eu-repo/semantics/openAccess
dc.subject L-carnitine
dc.subject lipid metabolism
dc.subject health claim
dc.subject PARENTERAL-NUTRITION
dc.subject REQUIREMENTS
dc.subject OXIDATION
dc.subject GUIDANCE
dc.subject CYCLE
dc.subject 416 Food Science
dc.title L-carnitine and contribution to normal lipid metabolism : evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 en
dc.type Article
dc.contributor.organization Department of Food and Nutrition
dc.contributor.organization Food Quality & Safety
dc.contributor.organization Food Sciences
dc.description.reviewstatus Peer reviewed
dc.relation.doi https://doi.org/10.2903/j.efsa.2018.5137
dc.relation.issn 1831-4732
dc.rights.accesslevel openAccess
dc.type.version publishedVersion

Files in this item

Total number of downloads: Loading...

Files Size Format View
Panel_et_al_2018_EFSA_Journal_4.pdf 565.9Kb PDF View/Open

This item appears in the following Collection(s)

Show simple item record